7.69MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00688A1060
CUSIP
00688A106
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
2.46
Dividend Share
-
Dividend Yield
-
Earnings Share
-2.94
Wall Street Target Price
7.5
EPS Estimate Current Year
-2.775
EPS Estimate Next Year
-1.415
EPS Estimate Current Quarter
-0.44
EPS Estimate Next Quarter
-0.4
Most Recent Quarter
-
Revenue TTM
0
Gross Profit TTM
0
EBITDA
-7,273,465
Profit Margin
0.00%
Return On Assets TTM
-104.18%
Return On Equity TTM
-320.96%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-2.94
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0
Price Book MRQ
1.3065
Enterprise Value Revenue
0
Enterprise Value EBITDA
0
473.97
2.63%788.75
1.37%208.00
1.15%525.60
0.00%170.35
-5.37%616.75
-1.12%89.57
-0.99%121.17
-0.46%255.49
-0.31%98.13
-0.03%